Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 39-4407731 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To promote Medical Research seeking treatments and a cure for Foxp1 syndrome and related disorders and to advocate for faster pathways from discovery to therapy, including through a) funding and support of scientific studies and therapeutic developments, b) fostering collaberation among researchers, clinicians, and families, and c) offering education about Foxp1 gene mutations and related disorders, and d) providing support for those affected by Foxp1 gene mutations.
Principal Officer
Mikhal Roman
Total Revenue
$50K
FY2025
Total Expenses
$21K
FY2025
Net Assets
$29K
Program Ratio
82.3%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.